Boothbay Fund Management’s GlucoTrack GCTK Stock Holding History
Bought
Maintained
Sold
Other funds holding GCTK
Boothbay Fund Management's GCTK Position: Q3 2026 in Review
Boothbay Fund Management sold out of GlucoTrack (GCTK) in Q3 2026, closing a stake of 451 shares — an estimated $4.31K sold.
Boothbay Fund Management first reported a position in GCTK in Q4 2025 and held it in 3 quarters. The position peaked at $52.3K in Q4 2025. 8 funds tracked by Wall St. Rank hold GCTK as of Q3 2026.
- Boothbay Fund Management reported no remaining GlucoTrack position as of Q3 2026 after selling out during the quarter.
- Boothbay Fund Management sold 451 GlucoTrack shares in Q3 2026, an estimated $4.31K.
- Boothbay Fund Management first reported a position in GlucoTrack in Q4 2025 and held it in 3 quarters.
- Boothbay Fund Management's GlucoTrack position peaked at $52.3K in Q4 2025.
- 8 funds tracked by Wall St. Rank held GlucoTrack as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.